To get all the latest updates about the podcast, see who we’ll have on next, as well as watch the video version of the pod, please follow us on twitter at and subscribe to the SNN Network YouTube Channel at For more information about Cove Street Capital, please visit: Įach new episode will be available every Tuesday morning on Apple, Spotify and all podcast streaming platforms.Īll opinions expressed by your hosts and the podcast guests are solely their own opinions and do not reflect the opinion of Cove Street Capital or any affiliates.
#Nasdaq vmd professional#
This episode of Compounders: The Anatomy of a Multibagger is sponsored by Tegus, an innovative and disruptive company that is changing the way professional investors work.
How the company thinks about adding new products and services to its current offerings. How the company is attracting and retaining talented people in a very tight labor market for healthcare workers and. and how Viemed can increases the penetration of non-invasive ventilation The size of the COPD population in the U.S. The attractiveness of in-home care relative to acute and outpatient case. The elements that have led to such rapid revenue growth. Given Viemed’s impressive recent track record and the amount of white space it has to continue to serve even more at-risk patients, I was looking forward to talking to Casesy about: Casey took over as CEO in 2017 and has helped the company grow its revenue meaningfully over that time, even accounting for the COVID headwinds the company has seen over the last few years. The company has developed a specialty in providing non-invasive ventilation to patients with chronic obstructive pulmonary disease or COPD. Viemed is a 196 million dollar market cap company that provides in-home durable medical equipment (DME) and post-acute respiratory healthcare services to patients in the United States. You should not assume that the securities discussed are or will be profitable.My guest on the show today is Casey Hoyt, the CEO of Viemed. The hosts and guests may be beneficial owners of the securities discussed. We are not recommending the purchase or sale of any securities. This podcast is for informational purposes only, it is not investment advice, and should not be relied upon for any investment decisions. 
My guest on the show today is Casey Hoyt, the CEO of Viemed.
0 kommentar(er)
